Numerical , albeit non-significant , improvement in acute exacerbations of COPD , SGRQ-C , CRQ-SAS , and FEV@ were greater in benralizumab-treated patients with baseline blood eosinophil concentrations of @ cells per L or more or @ cells per L or more .